We further analyzed the variation and methylation of GLP-1 signaling-related genes, which suggesting ADCY8 had the highest mutation rate in single nucleotide mutations and was inclined to be hypermethylated in pan-cancer. The gene discussed is GLP1R; the disease is cancer.